Announce: A Randomized, Placebo (Pbo)-Controlled, Double-Blind, Phase (Ph) Iii Trial Of Doxorubicin (Dox) Plus Olaratumab Versus Dox Plus Pbo In Patients (Pts) With Advanced Soft Tissue Sarcomas (Sts).William D. Tap,Andrew J. Wagner,Zsuzsanna Papai,Kristen N. Ganjoo,Chueh-Chuan Yen,Patrick Schoffski,Albiruni Ryan Abdul Razak,Javier Martin Broto,Alexander I. Spira,Akira Kawai,Anders Krarup-Hansen,Axel Le Cesne,Brian Van Tine,Yoichi Naito,Se Hoon Park,Victoria Soldatenkova,Gary Mo,Ashwin Shahir,Jennifer Wright,Robin Lewis JonesJOURNAL OF CLINICAL ONCOLOGY（2019）引用 69|浏览72暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
